AW Server 510 (k) Summary of Safety and Effectiveness



Similar documents
MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

February 5, Dear Kristin Pabst,

January 12, Dear Amy Yang:

GE Healthcare MAR

510(K) SUMMARY. 510(k) Number KOS'00-r

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

Ultimate Concepts Inc.

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

0 EC V-,) 133 Lj9a

Q(K SVJM~jPagelIof 3

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

BMR ~131o-lvleccai Kesearcn Ltd.

University of Texas Medical School at Houston. April 14, 2015

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

51O(K) SUMMARY: Therapy family of devices.

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

510(K) Summary K102148

(k)Suminary k

510(k) SUMMARY APR Date: 15 th December 2008

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

L~l t l V~! MAY ?

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

July 24, Dear Ms. Rhodes:

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

Manufacturing Technology, Inc.

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

March 20, Dear Mr. Chen:

May 5, Dear Mr. Courtney:

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

510(k) SUMMARY. OPTION-vyM Urinary Catheter

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

510(k) Summary. Dentsply Implants. April 30, 2013

March 3, Dear Ms. Alice Gong,

Section 5-510(k) Summary. This document is provided in the following pages. DEC

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

Fresenius Medical Care

JN (k) Summary Device Identification: Device Description:

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

DEC V,(9/azO (c 0 j

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

Dental Morelli Ltda.

510(k) Summary (c)

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

September 25, Dear Ms. McCoy:

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

October 29, Dear Ms. Hartnett:

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

MAY Attachment (k) Summary 21 CER

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

Summary of Safety and Effectiveness

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices

510(k) Summary of Safety SE K1

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

CDRH Regulated Software

510(k) Summary. (508) X222 Disposable Insulin Delivery Device

Transcription:

SEP 2 2008 GE Medical Systems AW Server 510 (k) Summary of Safety and Effectiveness This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87. 1. Identification of submitter: Author (Primary contact) US Designated Agent ( 2 n contact) Stephen Slavens Kirsten Schutz DI Global RA Premarket Director DI Qualit Assurance Director GE Healthcare GE Healthcare 3000 N Grandview Blvd, W706 3000 N Grandview Blvd, W706 -Waukesha, WI 53188 Waukesha, WI 53188 Tel: 262-548-4992 Tel: 262-312-7117 Fax: 262-548-4710 Fax: 262-544-3141 stephen.slavenspge.com kirsten.schutz~age.com 2. Identification of Product: -Device name AW Server -Classification name PACS per 21 CFR 892.2050 -Owner/Operator General Electric Manfacturing site General Electric Medical Systems SCS 283, Rue de la Mini~re 78533 BUG Cedex France 3. Marketed Devices AW Server is substantially equivalent to the devices listed below: Model: Advantage Workstation 4.3 Manufacturer: General Electric Medical Systems 510 (k): K(052995 Classification name: PACS per 21 CFR 892.2050 Regulatory Class: II Product Code: LLZ Model: AquariusNET Server Manufacturer: TeraRecon, Inc. 510 (k): K(012086 Classification name: PACS per 21 CFR 892.2050 System, Image processing per 21 CFR 829.2020 Regulatory Class: II Product Code: 90-LLZ, 90-LMD 1/3

0 GE Medical Systems 4. Device Description: AW Server is a medical software system that allows multiple users to remotely access AW applications from compatible computers on a network. The system allows networking, selection, processing and filming of multimodality DICOM images. Both the client and server software are only for use with off the shelf hardware technology that meets defined minimum specifications. The device is not intended for diagnosis of mammography images. The device is not intended for diagnosis of lossy compressed images. For other images, trained physicians may use the images as a basis for diagnosis upon ensuring that monitor quality, ambient light conditions and image compression ratios are consistent with clinical application. AW Server is a software package delivered with off-the-shelf server-class hardware that allows easy selection, review, processing and filming of multiple modality DICOM images from a variety of PC client machines, using LAN or WAN networks. It also allows user selectable loss-less and lossy compression schemes that are used in order to make a trade-off between speed and quality. AW Server is intended to be used in a manner similar to the current GE Medical Systems AW workstation product. It will be used to create and review diagnostic evidence related to radiology procedures by trained physicians in General Purpose Radiology, Oncology, Cardiology and Neurology clinical areas. AW Server, like Advantage Workstation 4.3, may be used with a variety of other GE software medical devices, which are cleared by FDA in their own names.. 5. Indications for Use AW Server is a medical software system that allows multiple users to remotely access AW applications from compatible computers on a network. The system allows networking, selection, processing and filming of multimodality DICOM images. Both the client and server software are only for use with off the shelf hardware technology that meets defined minimum specifications. The device is not intended for diagnosis of mammography images. The device is not intended for diagnosis of lossy compressed images. For other images, trained physicians may use the images as a basis for diagnosis upon ensuring that monitor quality, ambient light conditions and image compression ratios are consistent with clinical application. 2/3

GE Medical Systems 6. Comparison with Predicate Device The functional features of AW Server software package are substantially equivalent to that of the following devices: Device Name Advantage Workstation 4.3 AquariusNET Server FDA Clearance Number K052995 K012086 7. Adverse Effects on Health The potential hazards are identified in a risk management summary (hazard analysis) and are controlled by:, Software Development, Validation and Verification Process to ensure performance to specifications, Federal Regulations and user requirements. * Adherence to industry and international standards. 8. Conclusions AW Server does not result in any new potential safety risks and performs as well as devices currently on the market. GE considers features of the AW Server to be equivalent to predicate devices listed in section 6. GE has assessed and tested this device as a software moderate Level of Concern device. 3/3

DEPARTMENT OF HEALTH & HUMAN SERVICES SEP 2 5 2008 Public Health Service Food and Drug Administration 9200 Corporate Boulevard SRockville MD 20850 GE Medical Systems, LLC % Mr. Daniel W. Lehtonen Sr. Staff Engineer - Medical Devices Intertek Testing Services 2307 E. Aurora Rd., Unit B7 TWINSBURG OH 44087 Re: K081985 Trade/Device Name: AW Server Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: September 9, 2008 Received: September 10, 2008 Dear Mr. Lehtonen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and. adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA' may publish further announcements concerning your device in the Federal Register;

Page 2 Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: 21 CFR 876.xxx (Gastroenterology/Renal/Urology 240-276-0115 21 CFR 884.xxx (Obstetrics/Gynecology) 240-276-0115 21 CFR 894.xxx (Radiology) 240-276-0120 Other 240-276-0100 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276- 3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Enclosure Joyce M. Whang, Ph.D. Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

510(k) Number (if known): Device Name: AW SERVER Indications for Use: Indications for Use AW Server is a medical software system that allows multiple users to remotely access AW applications from compatible computers on a network. The system allows networking, selection, processing and filming of multimodality DICOM images. Both the client and server software are only for use with off the shelf hardware technology that meets defined minimum specifications. The device is not intended for diagnosis of mammography images. The device is not intended for diagnosis of lossy compressed images. For other images, trained physicians may use the images as a basis for diagnosis upon ensuring that monitor quality, ambient light conditions and image compression ratios are consistent with clinical application. Prescription Use X Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page _1 of _1 (Divisio'ign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number -